<DOC>
	<DOC>NCT00738205</DOC>
	<brief_summary>This is an international, multicenter study involving children treated with Saizen®, a growth hormone, who will be trained to use easypod, a new electronic injector and will complete a questionnaire after 12 week of use. Both children naïve to growth hormone and dissatisfied with their current injection device will be recruited.</brief_summary>
	<brief_title>Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector</brief_title>
	<detailed_description>An international, multicenter cross-sectional study (Observatoire des pratiques médicales®) involving a cohort of children treated with Saizen®, a growth hormone. The study does not require any changes to the usual medical management of these patients and should not be considered detrimental to their physical or psychological integrity. No specific procedures or examinations will be requested, nor does the protocol require any particular treatment or follow-up visits.</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Already treated patients who are dissatisfied with their current selfinjection device, or naïve pediatric patients, in cases for which this indication is validated (growth hormone deficiency, Turner's syndrome, chronic renal failure, smallforgestational age [SGA] patients, based on RCP) Cases in which Saizen® is contraindicated (based on local RCP) Children returning for consultation, who have not brought back their Easypod™ electronic selfinjector. Children who are participating in a therapeutic trial, or who have done so in the 3month period preceding their recruitment into this observational study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Electronic device</keyword>
	<keyword>Growth hormone treatment</keyword>
</DOC>